ArticleAdvances in difference equations2020
Modeling and forecasting the spread tendency of the COVID-19 in China.
Article in Advances in difference equations, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the first 3 years of the pandemic.Royal Society open science · 2025Article
- Stability and numerical analysis via non-standard finite difference scheme of a nonlinear classical and fractional order model.Results in physics · 2023Article
- Using simulation modelling and systems science to help contain COVID-19: A systematic review.Systems research and behavioral science · 2022Article
- EKF-SIRD model algorithm for predicting the coronavirus (COVID-19) spreading dynamics.Scientific reports · 2022Article
- Article
- Comparative study of artificial neural network versus parametric method in COVID-19 data analysis.Results in physics · 2022Article
- Mathematical Modeling to Determine the Fifth Wave of COVID-19 in South Africa.BioMed research international · 2022Article
- Mathematical modeling and optimal control of the COVID-19 dynamics.Results in physics · 2021Article
- Leveraging weather data for forecasting cases-to-mortality rates due to COVID-19.Chaos, solitons, and fractals · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To forecast the spread tendency of the COVID-19 in China and provide effective strategies to prevent the disease, an improved SEIR model was established. The parameters of our model were estimated based on collected data that were issued by the National Health Commission of China (NHCC) from January 10 to March 3. The model was used to forecast the spread tendency of the disease. The key factors influencing the epidemic were explored through modulation of the parameters, including the removal rate, the average number of the infected contacting the susceptible per day and the average number of the exposed contacting the susceptible per day. The correlation of the infected is 99.9% between established model data in this study and issued data by NHCC from January 10 to February 15. The correlation of the removed, the death and the cured are 99.8%, 99.8% and 99.6%, respectively. The average forecasting error rates of the infected, the removed, the death and the cured are 0.78%, 0.75%, 0.35% and 0.83%, respectively, from February 16 to March 3. The peak time of the epidemic forecast by our established model coincided with the issued data by NHCC. Therefore, our study established a mathematical model with high accuracy. The aforementioned parameters significantly affected the trend of the epidemic, suggesting that the exposed and the infected population should be strictly isolated. If the removal rate increases to 0.12, the epidemic will come to an end on May 25. In conclusion, the proposed mathematical model accurately forecast the spread tendency of COVID-19 in China and the model can be applied for other countries with appropriate modifications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.